Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PRC saw more insider buying this week at .57 50,000 shares, ...I think we should see a run up in OIL prices this week given the JULY 4th driving frenzy and greed of the oil co.s., and therefore a rise in PRC. I'm in.
More insider buying this week at .57 50,000 shares, ...I think we should see a run up in OIL prices this week given the JULY 4th driving frenzy and greed of the oil co.s., and therefore a rise in PRC.
OOOOOOOOOhhhhhhhhh yaaa, not those foldup type you get in a ceral box or Hanna Montana DVD with the single Blue right side and single red left side, but a pair of those IMAX 3D glasses...ever since my operations, I set off the theaters security system when they issue them.
Actually Paragraph 6 is the more telling, either way we should have news by July, if the are extending thier contract with COBRA, or if as they are strongly suggesting, that they are terminating the contract. If they are terminating it, I would imagine that they announce the new partner in manufacturing minimmally, but possibly for the R&D cost in the last and most costly PH 3.
Possible Scenario, partner has allready been chosen and is now in their own phase of accumulating stock before the announcement is made and we go VERTICAL.
JMHO
What is with the .02 spread on GNVC when it is trading barely above $1. I have not seen that kinda trading before...comments please
The Fast Track mechanism is described in the Food and Drug Administration Modernization Act of 1997 (FDAMA). The benefits of Fast Track include scheduled meetings to seek FDA input into development plans, the option of submitting a New Drug Application in sections rather than all components simultaneously, and the option of requesting evaluation of studies using surrogate endpoints (see Accelerated Approval below). The Fast Track designation is intended for the combination of a product and a claim that addresses an unmet medical need, but is independent of Priority Review and Accelerated Approval. An applicant may use any or all of the components of Fast Track without the formal designation. Fast Track designation does not necessarily lead to a Priority Review or Accelerated Approval. Priority Review is a designation for an application after it has been submitted to the FDA for review for approval of a marketing claim. Under the Food and Drug Administration Modernization Act (FDAMA), reviews for New Drug Applications are designated as either Standard or Priority. A Standard designation sets the target date for completing all aspects of a review and the FDA taking an action on the application (approve or not approve) at 10 months after the date it was filed. A Priority designation sets the target date for the FDA action at 6 months. A Priority designation is intended for those products that address unmet medical needs
100000 shares at the ask of 1.10 for GNVC, boy someone is trying to keep it down
so much for that taken out in the blink of an eye.
GNVC ...Bought 2000 more shares at 1.06
Lookout from 15h40 on with GNVC...there will be postion taking for the possibilty of AH news, because something is coming, just when??
CHCI also two days in a row of 12X normal volume no huge spike YET, but I believe it is coming...That's just me though.
Thanx Fringe, nice chrting and chart
Not meaning to take your words for mine, it seems we were posting around the same time, great minds think alike. What I meant about JAZZ Money coming in was only for the small pop we've seen in the past 10 minutes.
Again sorry I don't mean to step on any toes. Please don't hit me, I'm only 115 LBS and where glasses. LOL
I think we are seeing some JAZZ money coming into GNVC...GNVC should = JAZZ type move...soon.
Just my humble opinion
CHCI...KABOOM +44%....
GNVC closed the gap...now we shall see if it was real or just a head fake...shorts all over us
GNVC Volume is 15 X daily volume from last 3 mnths and 6 X daily volume from the last 10 days, and we are only half way thru the day....large short intrest getting squeezed....I see a double here within a few trading days
You are so correct....so correct
I've been living this myself for the past 4 1/2 years...I was originally diagnosed stage 4 Liver Cancer in January 2005, by March 2006 after a 20% liver section, I was told I had at most a year as my cancer had metastisized to my lungs. I went to another hospital....they looked at the same pathology reports and gave me the same diagnoses. I asked to be put into a Phase 1 drug trial. Thanx to my investing in pennies I knew about that possibility, most people have no clue. I was sent to another hospital and was signed into a gunie pig study, before it started, a specialist oncologist met me, saw my age, put me back intouch with one of the previous hospitals that gave me 1 yr to live. 23 surgeries later, including two liver transplants, colon resection, spinal tap surgery, and a plentitude of others, I am still here. I am not better, in fact now I have liver, lung, bone, and peritonal cancer. I was given 4 mths to live last June. Then again three weeks to live in December. I have surpassed them all, I'm on and off chemo, I weigh 115 at 5'11. but you know what is most important...I'M ALIVE!!! and I have just seen my son pass his 10th birthday, and my daughter her 6th. For you and your mom: DON'T GIVE UP!!! NEVER GIVE UP. Don't take no for an answer, and she makes the decisions not the doctors.
Paul
Just closed all my plays my ARIA position for a small gain and took a loss on ACLS...but I'm all Cash now....the Market is giving me the heebee jeebies
Stopped out HEB 1.65 locked in another $355 it still a profit
That is truly fantastic Duce, Congradulations and keep it up.
a million shares of ACLS traded today in just two minutes for .37 at 11H47 .......Things that make you say Hmmm.
tommorrow they present and if it will be then that it may move
MHO
got back in HEB at 1.39 with the same small position that I sold yesterday at 1.94
ARIA interesting news
SF investor discloses 10% stake in Ariad Boston Business Journal
Thursday, May 14, 2009, 12:37pm EDT | Modified: Thursday, May 14, 2009, 12:59pm
SF investor discloses 10% stake in Ariad
Boston Business Journal - by Craig M. Douglas
A San Francisco-based investor with local roots has acquired a roughly 10 percent stake in drug maker Ariad Pharmaceuticals Inc.
Mark Lampert, a former investment banker and the founder and sole shareholder of BVF Inc., a West Coast investment firm, disclosed in a regulatory filing late Thursday that he paid roughly $24 million for a 9.9 percent stake in Cambridge, Mass.-based Ariad. The purchases were made by a number of funds affiliated with BVF, according to the filing.
In the filing, Lampert said the stock purchases were made because Ariad shares “were undervalued and represented an attractive investment opportunity.” He will continue to review the investment “on a continuing basis and may engage in discussions with management and the board of directors” of Ariad, other holders of common stock and “other relevant parties concerning the business, operations, governance, strategy, capitalization, ownership and future plans” of the company, according to the filing.
Lampert, a former vice president with Oppenheimer & Co. in New York, previously held senior executive positions at Biotechnology Royalty Corp., Cambridge NeuroScience and NutraSweet Co.
According to a biography posted on the Web site of California-based Acumen Pharmaceuticals Inc., which lists Lampert as a director, the investor also worked for the Boston Consulting Group and holds degrees from Harvard College and Harvard Business School.
Ariad (Nasdaq: ARIA), which is researching potential cancer therapies, booked a $20.2 million loss in the first quarter , compared with a $17 million loss in the year-earlier period. The company had roughly $50.1 million in cash and cash equivalents on hand as of March 31.
Joining you in ARIA Chartinator, but for only 1000 shares, did some quick DD, could pop fast back to $3
Out HEB at 1.94 for 102% gain....I'm happy.....I'll watch for a chance to get back in if it fills this mornings gap or around that...all cash now except for 6000 shares of ACLS at .51.....holding but patience is running thin...The moment I sell it'll go
HEB Comments
4:51PM Hemispherx Biopharma comments on market activity; no material events that would explain the high volume market activity (HEB) 1.30 +0.38 : Co stated that in view of the unusual market activity in the Company's stock, the NYSE Amex has contacted the Company and requested that the Company issue a public statement indicating as to whether there are any corporate developments which may explain the unusual activity. The Company stated that there have been no material events other than as disclosed in its recent press releases and its filings with the Securities and Exchange Commission that would explain the high volume market activity.
Depends on May 25th judgement of FDA approval, if it passes.....then then it's blue sky, no approval...sell fast
HAs anyone noticed HEB moving up...LOL
Sold my DAN yesterday at 1.60...20% loss
Still Holding ACLS from .51 6000 shares
Just bought 500 HEB at .935
Nervous nelly I am watching this market lately...
ACLS >>>>Volume preceeds price...volume 3.5x normal at noon...
72% held by institutions, 11% insiders = small float
JMHO
I saw this on etoday , but also noticed they issued another boat load of shares at 1.50...lots of dilution
out KFN at 1.75 Made a Profit and that's what counts...never thought I would after hours yesterday.
my understanding is and trust me I don't understand much but arn't estimates always measured not including special charges, perhaps we can have some resident pros opinion
yes but then 400 went thru at 1.71..LOL...
Here is an interesting take from KFN's Yahoo board.
They need to learn to write better releases!
The loss included charges of $60.2M + $27M + $19.4M and a restructuring credit of $34.6.
If you add it all together you get: -13 + 60.2 + 27 + 19.4 - 34.6 = $59M profit.
Divided by 150.5M shares outstanding = 39 cents / share before charges.
Estimates were for 33 cents - 37 cents, so we beat.
No wonder there is not a selloff. Keep your shares, this is going up!
Ouch GNW fell $1 from the high it's close now bouncing back a bit...man am I glad I sold it this morning on the Gap....Oh well gap filled now....
KFN behaving weird...should have sold at the EOD still in the Black but can't trade AH
KFN make it a EOD run to $2 +
Come on KFN kick it in...is this another head fake...or end of day drive
deal....
I'm in lasalle, drop in next time...hope I'll still be alive